Search filters

List of works by Thierry Verbinnen

A 3-year follow-up study after treatment with simeprevir in combination with pegylated interferon-α and ribavirin for chronic hepatitis C virus infection.

scientific article published on 30 January 2018

Antiviral profiling of the capsid assembly modulator BAY41-4109 on full-length HBV genotype A-H clinical isolates and core site-directed mutants in vitro.

scientific article published on 21 June 2017

Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study

scientific article published on 13 March 2017

In Vitro Activity of Simeprevir against Hepatitis C Virus Genotype 1 Clinical Isolates and Its Correlation with NS3 Sequence and Site-Directed Mutants.

scientific article published on 21 September 2015

Pre-existence and Persistence of Resistant Minority Hepatitis C Virus Variants in Genotype 1-Infected Patients Treated With Simeprevir/Peginterferon/Ribavirin.

scientific article published on 14 March 2016

Prevalence of the hepatitis C virus NS3 polymorphism Q80K in genotype 1 patients in the European region

scientific article published on 19 January 2015

Virology analyses of HCV genotype 4 isolates from patients treated with simeprevir and peginterferon/ribavirin in the Phase III RESTORE study.

scientific article published on 3 October 2016

Virology analyses of HCV isolates from genotype 1-infected patients treated with simeprevir plus peginterferon/ribavirin in Phase IIb/III studies.

scientific article published on 28 November 2014

Virology analysis of chronic hepatitis B infected patients treated for 28 days with JNJ-56136379 monotherapy

scientific article published on 24 June 2020